Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Axsome Therapeutics (AXSM) Revenue: 2022-2024

Historic Revenue for Axsome Therapeutics (AXSM) over the last 3 years, with Dec 2024 value amounting to $385.7 million.

  • Axsome Therapeutics' Revenue rose 63.22% to $171.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $561.3 million, marking a year-over-year increase of 65.83%. This contributed to the annual value of $385.7 million for FY2024, which is 42.53% up from last year.
  • As of FY2024, Axsome Therapeutics' Revenue stood at $385.7 million, which was up 42.53% from $270.6 million recorded in FY2023.
  • In the past 5 years, Axsome Therapeutics' Revenue registered a high of $385.7 million during FY2024, and its lowest value of $50.0 million during FY2022.
  • For the 3-year period, Axsome Therapeutics' Revenue averaged around $235.4 million, with its median value being $270.6 million (2023).
  • Data for Axsome Therapeutics' Revenue shows a peak YoY soared of 440.80% (in 2023) over the last 5 years.
  • Over the past 3 years, Axsome Therapeutics' Revenue (Yearly) stood at $50.0 million in 2022, then skyrocketed by 440.80% to $270.6 million in 2023, then spiked by 42.53% to $385.7 million in 2024.